{
  "title": "Newsletter",
  "intro": "```json\n{\n  \"title\": \"LAI Weekly Intelligence: December 12, 2025\",\n  \"intro\": \"This week's intelligence highlights significant advances in long-acting injectable technologies, with strategic partnerships driving innovation and positive clinical outcomes demonstrating the sector's momentum.\",\n  \"tldr\": [\n    \"Nanexa and Moderna forge strategic partnership to develop PharmaShell extended-release technology\",\n    \"UZEDY demonstrates positive Phase 3 results, advancing extended-release injectable th",
  "tldr": [],
  "sections": []
}